Elite Pharmaceuticals, Inc. Proceeds from Sale of Intangible Assets
Elite Pharmaceuticals, Inc. (ELTP) reported Proceeds from Sale of Intangible Assets of $67.20 thousand for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfIntangibleAssets · last filed 2021-11-15
- Elite Pharmaceuticals, Inc. proceeds from sale of intangible assets for the quarter ending 2021-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from sale of intangible assets for the quarter ending 2020-12-31 was $12.53K.
- Elite Pharmaceuticals, Inc. proceeds from sale of intangible assets for the quarter ending 2020-09-30 was $3.40K.
- Elite Pharmaceuticals, Inc. proceeds from sale of intangible assets for the quarter ending 2020-06-30 was $51.28K.
- Elite Pharmaceuticals, Inc. proceeds from sale of intangible assets for fiscal 2021 was $67.20K.
- Elite Pharmaceuticals, Inc. proceeds from sale of intangible assets for fiscal 2019 was $350.00K.
| Period end | Proceeds from Sale of Intangible Assets 3 month | Proceeds from Sale of Intangible Assets 6 month | Proceeds from Sale of Intangible Assets 9 month | Proceeds from Sale of Intangible Assets 12 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-14 | $12.53K derived: sum of 2 quarters · filed 2021-06-14 | $15.92K derived: sum of 3 quarters · filed 2021-11-15 | $67.20K 10-K · filed 2021-06-14 |
| 2020-12-31 | $12.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $15.92K derived: sum of 2 quarters · filed 2021-11-15 | $67.20K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $3.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | $54.67K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $51.28K 10-Q · filed 2021-08-16 | |||
| 2019-03-31 | $350.00K 10-K · filed 2020-06-29 |